BMY · SUB~ · PE · DIRECCIÓN DE SANIDAD DE LA PNP

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB PHARMA ~0.80' «Consorcio Bristol-Myers Squibb Peru S.A-Perufarma S.A.» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 1 non-competitive contracts at the buyer «DIRECCIÓN DE SANIDAD DE LA PNP», 1,580,291 PEN (≈ $426,679); method direct (Contratación Directa); OCID ocds-dgv273-seacev3-1173501; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

BMY · SUB~ · PE · DIRECCIÓN DE SANIDAD DE LA PNP

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

426,679

Records behind the indicator

1

Found

4 October 2026

Code

W-03079

Reference

ocds-dgv273-seacev3-1173501

Reference

2015-10-05